Skip to main content


Page 189 of 208

  1. Chronic Obstructive Pulmonary Disease (COPD) and asthma are common chronic diseases that are frequently accompanied by depression and/or anxiety. However, symptoms of depression and anxiety are often not recog...

    Authors: Antoinette M Pommer, François Pouwer, Johan Denollet and Victor J M Pop
    Citation: Trials 2012 13:6
  2. Surgeons in the Netherlands, Canada and the US participate in the FAITH trial (Fixation using Alternative Implants for the Treatment of Hip fractures). Dutch sites are managed and visited by a financed central...

    Authors: Stephanie M Zielinski, Helena Viveiros, Martin J Heetveld, Marc F Swiontkowski, Mohit Bhandari, Peter Patka and Esther MM Van Lieshout
    Citation: Trials 2012 13:5
  3. Governments and donors all over Africa are searching for sustainable, affordable and cost-effective ways to improve the quality of malaria case management. Widespread deficiencies have been reported in the pre...

    Authors: Virginia Wiseman, Lindsay J Mangham, Bonnie Cundill, Olivia A Achonduh, Akindeh Mbuh Nji, Abanda Ngu Njei, Clare Chandler and Wilfred F Mbacham
    Citation: Trials 2012 13:4
  4. Gyejibongnyeong-hwan (GJBNH) is one of the most popular Korean medicine formulas for menstrual pain of dysmenorrhea. The concept of blood stagnation in Korean medicine is considered the main factor of causing ...

    Authors: Jeong-Su Park, Sunju Park, Chun-Hoo Cheon, Ho-Yeon Go, Seung-Ho Sun, Yong-Cheol Shin, Bo-Hyoung Jang and Seong-Gyu Ko
    Citation: Trials 2012 13:3
  5. Randomised trials evaluation of surgical interventions are often designed and analysed as if the outcome of individual patients is independent of the surgeon providing the intervention. There is reason to expe...

    Authors: Jonathan A Cook, Thomas Bruckner, Graeme S MacLennan and Christoph M Seiler
    Citation: Trials 2012 13:2
  6. Patients with ST-elevation myocardial infarction (STEMI) not treated with primary or rescue percutaneous coronary intervention (PCI) are at risk for recurrent ischemia, especially when viability in the infarct...

    Authors: Ramon B van Loon, Gerrit Veen, Leo H B Baur, Otto Kamp, Jean G F Bronzwaer, Jos W R Twisk, Freek W A Verheugt and Albert C van Rossum
    Citation: Trials 2012 13:1
  7. Fresh frozen plasma (FFP) is an effective therapy to correct for a deficiency of multiple coagulation factors during bleeding. In past years, use of FFP has increased, in particular in patients on the Intensiv...

    Authors: Marcella CA Müller, Evert de Jonge, M Sesmu Arbous, Angelique ME Spoelstra -de Man, Atilla Karakus, Margreeth B Vroom and Nicole P Juffermans
    Citation: Trials 2011 12:266
  8. Poorly controlled hypertension (HTN) remains one of the most significant public health problems in the United States, in terms of morbidity, mortality, and economic burden. Despite compelling evidence supporti...

    Authors: Antoinette Schoenthaler, Leanne Luerassi, Jeanne A Teresi, Stephanie Silver, Jian Kong, Taiye Odedosu, Samantha Trilling, Anna Errico, Oshevire Uvwo, Kimberly Sebek, Adetutu Adekoya and Gbenga Ogedegbe
    Citation: Trials 2011 12:265
  9. Exercise programmes can be administered successfully as therapeutic agents to patients with a number of chronic diseases and help to improve physical functioning in older adults. Usually, such programmes targe...

    Authors: Timo Hinrichs, Anna Moschny, Michael Brach, Stefan Wilm, Renate Klaaßen-Mielke, Matthias Trampisch and Petra Platen
    Citation: Trials 2011 12:263
  10. The aim of this study was to evaluate the antiplaque effect of a new alcohol free essential oil mouthwash with respect to a control of an essential oil with alcohol mouthwash, using an in vivo plaque regrowth mod...

    Authors: Enrico Marchetti, Stefano Mummolo, Jonathan Di Mattia, Fabio Casalena, Salvatore Di Martino, Antonella Mattei and Giuseppe Marzo
    Citation: Trials 2011 12:262
  11. High quality evidence indicates that aspirin is effective in reducing colorectal polyps; and numerous epidemiological studies point towards an ability to prevent colorectal cancer. However the role of Aspirin ...

    Authors: Raghib Ali, Han-Chong Toh and Whay-Kuang Chia
    Citation: Trials 2011 12:261
  12. Asthma is a prevalent and costly disease resulting in reduced quality of life for a large proportion of individuals. Effective patient self-management is critical for improving health outcomes. However, key as...

    Authors: Sara Ahmed, Susan J Bartlett, Pierre Ernst, Guy Paré, Maria Kanter, Robert Perreault, Roland Grad, Laurel Taylor and Robyn Tamblyn
    Citation: Trials 2011 12:260
  13. People with multiple sclerosis (MS) are at high risk of depression. We undertook a pilot trial of computerised cognitive behavioural therapy (CCBT) for the treatment of depression in people with MS to test the...

    Authors: Cindy L Cooper, Daniel Hind, Glenys D Parry, Claire L Isaac, Munyaradzi Dimairo, Alicia O'Cathain, Anita Rose, Jennifer V Freeman, Leonie Martin, Eva C Kaltenthaler, Anna Thake and Basil Sharrack
    Citation: Trials 2011 12:259
  14. Authors: Kimberley Goldsmith, Trudie Chalder, Peter White, Michael Sharpe and Andrew Pickles
    Citation: Trials 2011 12(Suppl 1):A144

    This article is part of a Supplement: Volume 12 Supplement 1

  15. Authors: Frank M Sullivan, Shaun Treweek, Anile Grant, Fergus Daly, Donald Nicolson, Brian McKinstry, Janet Hanley, Jenny Ure and Aziz Sheikh
    Citation: Trials 2011 12(Suppl 1):A115

    This article is part of a Supplement: Volume 12 Supplement 1

  16. Authors: Roger A’Hern, Johann DeBono, Shahneen Sandhu, Eletheria Kalaitzaki, Martine Usdin and Emma E Hall
    Citation: Trials 2011 12(Suppl 1):A88

    This article is part of a Supplement: Volume 12 Supplement 1

  17. Authors: Sarah Meredith, Martyn Ward, Gillian Booth, Andrew Fisher, Carrol Gamble, Heather House and Martin Landray
    Citation: Trials 2011 12(Suppl 1):A39

    This article is part of a Supplement: Volume 12 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    5,569 Altmetric mentions